Beam Therapeutics Inc. (BEAM) Dividend History

Beam Therapeutics Inc. (BEAM) is a biotechnology company focused on developing precision genetic medicines using base editing technology. Founded to create targeted therapies for genetic diseases, Beam Therapeutics leverages its innovative editing platform to make precise, single-nucleotide modifications in DNA, aiming to treat serious medical conditions with fewer off-target effects.

26 Landsdowne Street, Cambridge, MA, 02139
Phone: 857-327-8775
Website: https://www.beamtx.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
March 03, 2014	$0.22	02/04/2014	02/06/2014
December 02, 2013	$0.22	11/04/2013	11/06/2013
September 03, 2013	$0.23	08/12/2013	08/14/2013
June 03, 2013	$0.22	05/06/2013	05/08/2013
March 01, 2013	$0.22	02/04/2013	02/06/2013
December 03, 2012	$0.20	11/05/2012	11/07/2012
September 04, 2012	$0.20	08/06/2012	08/08/2012
June 01, 2012	$0.20	05/07/2012	05/09/2012
March 01, 2012	$0.20	02/06/2012	02/08/2012
December 01, 2011	$0.19	11/07/2011	11/09/2011
September 01, 2011	$0.19	08/08/2011	08/10/2011
June 01, 2011	$0.19	05/09/2011	05/11/2011
March 01, 2011	$0.19	02/07/2011	02/09/2011
December 01, 2010	$0.19	11/08/2010	11/10/2010
September 01, 2010	$0.19	08/09/2010	08/11/2010
June 01, 2010	$0.19	05/10/2010	05/12/2010
March 01, 2010	$0.19	02/08/2010	02/10/2010
December 01, 2009	$0.19	11/02/2009	11/04/2009
September 01, 2009	$0.19	08/10/2009	08/12/2009
June 01, 2009	$0.19	05/11/2009	05/13/2009
March 02, 2009	$0.44	02/09/2009	02/11/2009
December 01, 2008	$0.44	11/07/2008	11/12/2008
September 02, 2008	$0.44	08/11/2008	08/13/2008
June 02, 2008	$0.42	05/12/2008	05/14/2008
March 03, 2008	$0.42	02/04/2008	02/06/2008
December 03, 2007	$0.42	11/05/2007	11/07/2007
September 04, 2007	$0.42	08/13/2007	08/15/2007
June 01, 2007	$0.39	05/07/2007	05/09/2007
March 01, 2007	$0.39	02/05/2007	02/07/2007
December 01, 2006	$0.39	11/06/2006	11/08/2006
September 01, 2006	$0.39	08/07/2006	08/09/2006
June 01, 2006	$0.36	05/08/2006	05/10/2006
March 01, 2006	$0.36	02/06/2006	02/08/2006
December 01, 2005	$0.36	11/07/2005	11/09/2005
September 01, 2005	$0.36	08/03/2005	08/05/2005
June 01, 2005	$0.33	05/09/2005	05/11/2005
March 01, 2005	$0.33	02/07/2005	02/09/2005
December 01, 2004	$0.33	11/08/2004	11/10/2004
September 01, 2004	$0.33	08/09/2004	08/11/2004
June 01, 2004	$0.30	05/10/2004	05/12/2004
March 01, 2004	$0.30	02/09/2004	02/11/2004

Dividends Summary

Beam Therapeutics Inc. has issued 41 dividend payments over the past 10 years
The most recent dividend was paid 4114 days ago, on March 3, 2014
The first recorded dividend was paid on March 1, 2004
The highest dividend payout was $0.44 per share
The average dividend over this 10 year span is $0.29 per share
Beam Therapeutics Inc. has decreased its dividend payments by 25.00% since 2004

Company News

Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Beam Therapeutics announced that the FDA has granted orphan drug designation to BEAM-302, a potential treatment for alpha-1 antitrypsin deficiency (AATD), a rare genetic disorder affecting the lungs and liver. The designation provides benefits to support the development and evaluation of BEAM-302, which has shown promising initial safety and efficacy data in a Phase 1/2 trial.

GlobeNewswire Inc.
Why Beam Therapeutics Stock Tanked on Tuesday

Beam Therapeutics, a gene-editing company, reported Q1 earnings that missed analyst expectations, leading to a 19% drop in its stock price. The company's cash runway extends into 2028, which could give it time to develop its pipeline programs.

The Motley Fool
Beam Therapeutics Announces Pricing of Underwritten Offering

Beam Therapeutics, a biotechnology company, announced the pricing of a $500 million public offering of its common stock and pre-funded warrants. The company plans to use the proceeds to advance its base editing platform, research and development, and potential pivotal trials.

GlobeNewswire Inc.
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences

Beam Therapeutics, a biotechnology company developing precision genetic medicines, announced that it will participate in fireside chats at upcoming investor conferences in March 2025.

GlobeNewswire Inc.
Beam Therapeutics to Participate in Guggenheim SMID Cap Biotech Conference

Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, announced that its CEO John Evans will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on February 6, 2025.

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 15:11:10 UTC

Beam Therapeutics Inc. (BEAM) Dividend History

Dividend History

Dividends Summary

Company News

Related Companies